Your leading voice in digital health news
Twitter X Logo

Personalised medicine: World-first trial for children’s brain tumours

3 February 2026
By Pulse+IT
A world-first clinical trial will test cancer vaccines designed specifically for children with advanced or treatment-resistant brain tumours, following a $2.578 million investment from the Australian Government. The study – co-led by The University of Queensland and the South Australian Health and Medical Research Institute (SAHMRI) and partnered with mRNA medicines platform company Providence Therapeutics […]

Subscribe to read more

Pulse+IT website access

Keep your finger on the pulse with full access to all articles published on pulseit.news
Instant access
All articles
Cancel anytime

Your leading voice in digital health news

Twitter X

Your leading voice in digital health news 

Keep your finger on the pulse with full access to all articles published on 
pulseit.news
Subscribe from only $39
magnifiercrossmenuchevron-down